News Sentiment

NRXP sentiment intelligence

NRX Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed

Weighted score 52 Balanced news tone 58 relevant articles

Exchange NASDAQ United States

Sector Healthcare Market context

Industry Biotechnology Read-through group

Latest close 4.19 Week of 10 Jul 2026

Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

79/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

+8.3% over one week, +9.1% over four weeks, trend active, and materially above fair value.

Latest direct headline Positive

Is NRx Pharmaceuticals, Inc. (NRXP) Stock Positioned for Growth Through Depression and PTSD Treatment Innovation?

Market Reaction

Price moving ahead of tone

60/100 confidence

Primary event Market update 79/100 classification

One-week reaction 8.3% Price confirming higher

Trend fit Trend active 9.1% over four weeks

Fair value 46.9% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance

Positive 14

Neutral 35

Negative 9

Relevance

Why the article matched

Direct first

Direct company coverage 50

Industry context 8

Sector context 0

Sources

Coverage mix

Publishers

Market source 19

TradingView 11

Stock Titan 6

MT Newswires 3

simplywall.st 3

GlobeNewswire 2

Investing News Network 2

TradingKey 2

Event Lens

What the news is about

Classified themes

Market update 30

Earnings 15

Deals and strategy 4

Regulatory and legal 4

Guidance 2

Analyst action 2

Balance sheet 1

Sentiment Trail

Score over time

50 baseline

Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-58 of 58

TradingKey Direct company coverage

NRX Pharmaceuticals Inc (NRXPW) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of NRX Pharmaceuticals Inc (NRXPW), detailing its current stock price, market capitalization, and various technical indicators. It shows that most indicators, including MACD, CCI, TRIX, and all moving averages (MA5 to MA200), are signali

Tone: Negative 15/100
Event: Market update
Published: 20 Jun 2026 15:40
Source: TradingKey

Intellectia AI Direct company coverage

NRXP Should I Buy

Intellectia AI recommends a "Hold" rating for NRX Pharmaceuticals (NRXP) for beginner investors, citing a lack of recent financial data, neutral technical indicators, and no significant trading trends. Despite optimistic analyst ratings and potential market opportunities in the k

Tone: Neutral 50/100
Event: Analyst action
Published: 19 Jun 2026 23:10
Source: Intellectia AI

Market source Direct company coverage

NRx Pharmaceuticals (NRXP) Closes Underwritten Public Offering of Common Stock At $3.50 Per Share

Tone: Neutral 50/100
Event: Market update
Published: 10 Jun 2026 07:00
Source: Market source

Stock Titan Direct company coverage

NRx Pharmaceuticals (NASDAQ: NRXP) closes $22.3M stock sale

Tone: Neutral 50/100
Event: Market update
Published: 04 Jun 2026 07:00
Source: Stock Titan

Market source Direct company coverage

NRx Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

Tone: Neutral 50/100
Event: Market update
Published: 03 Jun 2026 07:00
Source: Market source

Market source Direct company coverage

Here is why NRx Pharmaceuticals, Inc. (NRXP) is among the Best Rated Penny Stocks to Buy According to Wall Street Analysts

Tone: Positive 66/100
Event: Market update
Published: 24 May 2026 07:00
Source: Market source

Stock Titan Direct company coverage

Nasdaq withdraws NRXP Warrant listing (NRXP) — Form 25 notice

Tone: Neutral 50/100
Event: Market update
Published: 22 May 2026 07:00
Source: Stock Titan

Seeking Alpha Direct company coverage

NRx Pharmaceuticals: 'Sell' On ZYESAMI/NRX-101 Failures & Depression Market Uncertainty (NASDAQ:NRXP)

Tone: Negative 34/100
Event: Market update
Published: 20 May 2026 07:00
Source: Seeking Alpha

Stock Titan Direct company coverage

Anson Funds discloses 1.74M shares in NRX Pharmaceuticals (NRXP)

Tone: Neutral 50/100
Event: Market update
Published: 15 May 2026 07:00
Source: Stock Titan

Market source Direct company coverage

NRx Pharmaceuticals, Inc. (NRXP) Reports Q1 Loss, Lags Revenue Estimates

Tone: Negative 34/100
Event: Earnings
Published: 15 May 2026 07:00
Source: Market source

simplywall.st Industry context

There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings

Tone: Negative 34/100
Event: Earnings
Published: 15 May 2026 07:00
Source: simplywall.st

Market source Industry context

Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings

Tone: Neutral 50/100
Event: Earnings
Published: 14 May 2026 07:00
Source: Market source

simplywall.st Industry context

Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results

Tone: Positive 66/100
Event: Earnings
Published: 11 May 2026 07:00
Source: simplywall.st

Market source Industry context

Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00

Tone: Neutral 50/100
Event: Earnings
Published: 11 May 2026 07:00
Source: Market source

Market source Industry context

Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks

Tone: Neutral 50/100
Event: Earnings
Published: 25 Apr 2026 07:00
Source: Market source

Market source Industry context

Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)

Tone: Neutral 50/100
Event: Earnings
Published: 21 Apr 2026 07:00
Source: Market source

Market source Direct company coverage

NRx Pharmaceuticals (NASDAQ:NRXP) Is In A Good Position To Deliver On Growth Plans

Tone: Positive 66/100
Event: Market update
Published: 29 Mar 2026 07:00
Source: Market source

simplywall.st Direct company coverage

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Has Found A Path To Profitability

Tone: Neutral 50/100
Event: Market update
Published: 29 Mar 2026 07:00
Source: simplywall.st

TradingView Industry context

A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack

Tone: Neutral 50/100
Event: Earnings
Published: 29 Mar 2026 07:00
Source: TradingView

Market source Direct company coverage

NRx Pharmaceuticals (NRXP) Looks to Score Double With ANDA and NDA Filings For NRX-101

Tone: Neutral 50/100
Event: Market update
Published: 25 Mar 2026 07:00
Source: Market source

Stock Titan Direct company coverage

NRx Pharmaceuticals (NRXP) investors OK incentive plan and board slate

Tone: Neutral 50/100
Event: Market update
Published: 24 Mar 2026 07:00
Source: Stock Titan

Market source Direct company coverage

NRx Pharmaceuticals, Inc. (NRXP) Surpasses Q4 Earnings Estimates

Tone: Neutral 50/100
Event: Earnings
Published: 23 Mar 2026 07:00
Source: Market source

Market source Direct company coverage

NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Bioequivalence Determination by Office of Generic Drugs for NRx’s Preservative-Free Ketamine Application

Tone: Neutral 50/100
Event: Market update
Published: 17 Mar 2026 07:00
Source: Market source

Market source Direct company coverage

NRx Pharmaceuticals (Nasdaq:NRXP) Announces 70,000 Patient Data on Real World Use of Ketamine for Treatment of Suicidal Depression to be Submitted to the FDA in Support of NRX-100 Approval

Tone: Neutral 50/100
Event: Regulatory and legal
Published: 14 Jan 2026 08:00
Source: Market source

Investing News Network Direct company coverage

HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. Announce Inclusion of Cohen & Associates, LLC of Sarasota, FL into the HOPE Network and Appointment of Dr. Rebecca Cohen as HOPE Medical Director

Tone: Neutral 50/100
Event: Market update
Published: 20 Oct 2025 07:00
Source: Investing News Network

TradingKey Direct company coverage

NRXP|NRX Pharmaceuticals Inc|Price:4.185|Chg%:+0.075

Tone: Neutral 50/100
Event: Market update
Published: 09 Oct 2025 17:03
Source: TradingKey

PR Newswire Direct company coverage

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces Filing of Commissioner's National Priority Voucher Application for Intravenous Ketamine (NRX-100)

Tone: Neutral 50/100
Event: Market update
Published: 23 Jun 2025 07:00
Source: PR Newswire

Market source Direct company coverage

NRx Pharmaceuticals, Inc. (NRXP): Among the Best Psychedelic Stocks to Buy in 2025

Tone: Positive 66/100
Event: Market update
Published: 01 Mar 2025 08:00
Source: Market source